May 6, 2020 / 11:48 AM / 24 days ago

BRIEF-Blueprint Medicines Reports Q1 Loss Per Share $2.11

May 6 (Reuters) - Blueprint Medicines Corp:

* BLUEPRINT MEDICINES REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $2.11

* Q1 REVENUE $6.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $5 MILLION

* Q1 EARNINGS PER SHARE ESTIMATE $-2.08 — REFINITIV IBES DATA

* ON TRACK TO SUBMIT NDA TO FDA FOR PRALSETINIB FOR PREVIOUSLY TREATED RET MUTANT MTC IN Q2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below